申请人:Leleti Reddy Manmohan
公开号:US20070254915A1
公开(公告)日:2007-11-01
The present invention is directed to novel compounds and pharmaceutical compositions that inhibit the binding of the SDF-1 chemokine to the chemokine receptor CXCR4 and/or the binding of the SDF-1 or I-TAC chemokines to the chemokine receptor CCXCKR2 (CXCR7). These compounds are useful in preventing tumor cell proliferation, tumor formation, metastasis, inflammatory diseases, treatment of HIV infectivity, treatment of stem cell differentiation and mobilization disorders, and ocular disorders.
本发明涉及新型化合物和药物组合物,可抑制SDF-1趋化因子与趋化因子受体CXCR4的结合,和/或抑制SDF-1或I-TAC趋化因子与趋化因子受体CCXCKR2(CXCR7)的结合。这些化合物可用于预防肿瘤细胞增殖、肿瘤形成、转移、炎症性疾病、治疗HIV感染、治疗干细胞分化和动员障碍,以及眼部疾病的治疗。